LIVN logo

LivaNova PLC (LIVN)$73.83

Market Cap: 1.98 BCurrency: USD

Research Snapshot

Static fundamentals, valuation context, and investor signals for LivaNova PLC (LIVN).

HEALTHCARE
MEDICAL DEVICES
DCF ready

Valuation

9.9x

EV/FCF, 10.1% FCF yield

Quality

-15.4%

ROIC, 12.5% FCF margin

Growth

8.2%

5Y sales (revenue) CAGR

Balance sheet

0.3x

Debt/equity, 1.4x current ratio

Superinvestors

1

Top: Lee Ainslie (0.0%)

Strengths to research

  • Revenue compounded at 8.2% over five years.
  • Free cash flow margin is healthy at 12.5%.
  • Debt/equity looks manageable at 0.3x.
  • 10 annual periods are available for trend analysis.

Watchouts

No major valuation, balance sheet, or growth watchouts were detected by the static screen.

Annual data: 10 periods
Quarterly data: 24 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026

Quality Scorecard

Build-time composite score for LIVN.

Grade C
46
/ 100

Peer Comparison

Target stock against 8 market-cap comparable peers.

Heat map: red worst to green best
LIVN
Target
LivaNova PLC$2.0B-16.6x9.9x-15.4%8.2%12.5%67.7%-1.1xN/A
ENOVEnovis Corp.$2.0B-1.2x161.2x-42.5%14.9%0.9%59.8%5.7xN/A
QDELQuidelOrtho Corp.$1.9B-0.7x-53.0x-24.5%10.4%-3.0%N/AN/AN/A
AHCOAdaptHealth Corp.$1.2B-20.1x12.8x-2.2%25.2%6.8%N/A3.4xN/A
IARTIntegra LifeSciences Holdings$1.0B-2.2x-48.9x-29.2%3.6%-1.9%N/AN/AN/A
AORTArtivion Inc.$1.0B107.0x1388.5x1.5%11.8%0.2%64.4%2.7xN/A
ITGRInteger Holdings Corp.$4.1B30.9x49.8x3.5%11.5%5.7%27.0%3.3xN/A
INMDInMode Ltd.$868.1M9.6x6.7x13.7%12.4%22.7%78.5%-3.5xN/A
BRKRBruker Corp.$6.2B-304.6x178.8x-0.2%11.6%1.3%45.9%5.4xN/A

Financial Charts

No financial data available for LIVN (annual).

1 superinvestors own LIVN

Current quarter ownership and quarter-over-quarter share changes.

Superinvestor ownership
FundSharesValue% PortfolioQoQ Change
Lee Ainslie

Maverick Capital

15,044$956,0000.01%0.0%